Home » More precise tumor treatment thanks to the superconducting ASG superconductor technology

More precise tumor treatment thanks to the superconducting ASG superconductor technology

by admin
More precise tumor treatment thanks to the superconducting ASG superconductor technology

11.01.2024 – 11:53

ASG Superconductors

Genoa, Italy and Dresden, Germany (ots/PRNewswire)

ASG Superconductors’ (ASG) superconducting MgB2 technology – already used for energy and medical applications such as the world‘s only truly open MROpenEVO magnetic resonance imaging (MRI) system – is at the heart of the world‘s first in the field of proton therapy and Cancer treatment using real-time MRI imaging.

MRI offers the advantage over conventional imaging procedures in that it can display tumors with unsurpassed soft tissue contrast. This makes it possible to better differentiate the tumor from the surrounding healthy tissue and to define the volume to be irradiated more precisely. In addition, MRI guidance is able to map changes in the shape and size of the volume to be irradiated that occur between successive treatment sessions, so that the radiation application can be individually and immediately adjusted. One of the key points of this scientific and technological breakthrough that will impact cancer treatment is real-time MRI, which makes it possible to visualize the movement of the tumor during a radiation session and to synchronize it with the radiation application.

With the prototype presented today in Germany at Oncoray – the National Center for Radiation Research in Oncology – it will in fact be possible for the first time in the world to study to what extent the accuracy of proton therapy using real-time MRI for the entire Body can be improved. The head of the “Experimental MR-integrated proton therapy” research group, Prof. Aswin Hoffmann, with whom the ASG engineers have been working on the development of the new system for years, said: “With this new prototype of the integrated whole-body MRI, it is possible to move Imaging tumors with high-contrast images in real time. The aim of our work is to develop a technique with which moving tumors can only be irradiated if they are in the right position to be hit by the proton beam. The MRI device , which can be rotated around the patient, offers the opportunity to use innovative ways of positioning the patient to treat them with protons in both a lying and upright position.”

See also  Delivering the law to the door and delivering the service to the home

The prototype, based on the ASG technology already used for the MROpenEVO system, the world‘s only MRI machine with a completely open design and cryogen-free MgB2 superconductor technology, is intended to demonstrate in scientific studies the added value of this new treatment modality for tumors in the breast -, abdominal and pelvic areas. The development and installation as well as the commissioning were made possible through close cooperation with international technology and industrial partners, such as ASG Superconductors, which is not only the manufacturer of the MRI device used as a basis, but also has historical know-how in development, Design and manufacture of superconducting MRI magnets from 0.5T up to Ultra High Field 11.7T, while MagnetTx Oncology Solutions, Edmonton/Canada, designed the rotating technology part.

Marco Nassi, Managing Director of ASG Superconductors, said: “It is a great challenge to contribute to such an innovative technical and scientific project in the field of proton therapy in close collaboration with highly respected hospitals, partners and universities. We are all the more proud that our technologies and expertise in the area of ​​superconducting MgB2 material, magnets and MRI systems can make a significant contribution to making tumor treatment more effective in the near future.”

Further information about ASG Superconductors

www.asgsuperconductors.com

More information about MgB2 open MRI technology

www.mropenevo.com

Further information about the scientific project

https://www.oncoray.de/

Photo – https://mma.prnewswire.com/media/2315501/ASG_Superconductors.jpg

Logo – https://mma.prnewswire.com/media/1949000/ASG_Logo.jpg

View original content: https://www.prnewswire.com/news-releases/prazisere-tumorbehandlung-dank-der-supraleitenden-asg-supraleiter-technologie-302032571.html

Press contact:

LUCA PEZZONI,
+393389414437,
[email protected]

Original content from: ASG Superconductors, transmitted by news aktuell

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy